TyraTech, Inc. Result of Special Meeting & Director Shareholdings (5471N)
July 28 2014 - 12:35PM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 5471N
TyraTech, Inc.
28 July 2014
For immediate release
TyraTech, Inc
("TyraTech" or "the Company")
RESULT OF SPECIAL MEETING AND DIRECTORS' SHAREHOLDINGS
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR
DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO
OR FROM JAPAN, CANADA OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE
TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS
OF SUCH JURISDICTION.
Further to the announcement dated 16 July 2014, TyraTech, Inc.
(AIM: TYR and TYRU), a life sciences company focusing on
nature-derived insect and parasite control products, is pleased to
announce that at the Special Meeting held earlier today, each of
the resolutions as set out in the notice of Special Meeting was
duly passed. Accordingly, the Fundraise (as defined in the circular
dated 16 July 2014) is now unconditional save for Admission.
Accordingly, the Company has approved, subject only to
Admission, the issue of 50,000,000 new common shares in the capital
of the Company of $0.001 each (the "New Common Shares") at 7 pence
per share to the investors participating in the Fundraise.
Application has been made to the London Stock Exchange for the
New Common Shares to be admitted to trading on AIM ("Admission").
It is now expected that Admission and the commencement of dealings
will take place at 8 a.m. on 31 July 2014.
Following Admission, the Company will have 256,168,068 common
shares of $0.001 each ("Common Shares") in issue, of which
1,084,413 will continue to be held in Treasury. Therefore, the
total number of voting rights in the Company will be 255,083,655
("Total Voting Rights"). The number of restricted Common Shares
trading under TIDM 'TYR' following Admission will be 161,266,592
and the number of unrestricted Common Shares trading under TIDM
'TYRU' following Admission will be 94,901,476.
Furthermore, following Admission, there are changes to the
following directors' holdings of Common Shares:
Alan Reade, who subscribed for 214,298 New Common Shares
pursuant to the Subscription, is now interested in 12,700,656
Common Shares in the Company; representing an interest of 4.98% of
the total voting rights of the Company.
Bruno Jactel, who subscribed for 142,857 New Common Shares
pursuant to the Subscription, is now interested in 2,002,424 Common
Shares in the Company; representing an interest of 0.79% of the
total voting rights of the Company.
Barry Riley, who subscribed for 142,857 New Common Shares
pursuant to the Subscription, is now interested in 3,198,413 Common
Shares in the Company; representing an interest of 1.25% of the
total voting rights of the Company.
James Hills, who subscribed for 142,857 New Common Shares
pursuant to the Subscription, is now interested in 1,190,757 Common
Shares in the Company representing an interest of 0.47% of the
total voting rights of the Company.
END
For further information please contact:
TyraTech Inc.
Alan Reade, Non-executive Chairman Tel: +1 919 415 4310
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4280
SPARK Advisory Partners Limited, Nominated Adviser Tel: +44 20 3368 3551
Mark Brady/Matt Davis
Allenby Capital, Joint Broker Tel: +44 20 3328 5656
Chris Crawford
Whitman Howard Ltd, Joint Broker Tel: +44 20 087 4555
Ranald McGregor Smith/Niall Devins
Walbrook, Financial PR and IR Tel: +44 20 7933 8792
Bob Huxford / Guy McDougall
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFVRDSITFIS
Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024